bioMérieux (EPA:BIM) shares have continued recent momentum with a 30% gain in the last month alone. The full year gain of 40% is pretty reasonable, too. All else being equal, a sharp share price ...

Mérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE® SPOTFIRE® for pharmaceutical industries, where this innovative molecular testing system is designed to ...

MARCY L'ÉTOILE, France and SHERBROOKE, QC, Jan. 15, 2024 /CNW/ - bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of LUMED, a software company that has ...

PARIS, Sept 4 (Reuters) - French biotech firm BioMerieux will buy privately-owned U.S. rival BioFire Diagnostics for $450 million, in a deal aimed at consolidating its position as a major player in ...

MARCY-L'ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ -- bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to ...

Reinforces Baxter and bioMérieux’s shared commitment to enhancing acute kidney injury (AKI) management through informed clinical decision-making and patient-centered approaches Aids hospitals in ...

Biomerieux (BIOX) has delivered a -19.74% change over the past year, with a 52-week range between 87.60 and 128.30. What Is the Average Daily Trading Volume of Biomerieux (BIOX)? The average daily ...

MARCY L’ÉTOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition ...

- Co-development of Assays and Co-distribution of a Fully Integrated Molecular Platform due for Launch in 2012 - bioMerieux Gains Exclusive Rights in Microbiology - bioMerieux Takes Equity Stake in ...

The Navy Yard’s newest tenant moved to the neighborhood to double down on Philly’s talent and manufacturing opportunities. French molecular diagnostics company BioMérieux opened its genomics and ...